Rosalia Lira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rosalia Lira has a total of 236 co-authors. Here are the top co-authors by number of shared publications:
- Angélica Maldonado-Rodríguez
Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, UMAE Hospital de Pediatría, CMN Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de Mexico 06720, Mexico
6 shared publications - Beatriz Xoconostle-Cázares
Departamento de Bioingeniería y Biotecnología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Av. IPN 2508, Ciudad de México, 07360, México
5 shared publications - David Sacks
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
5 shared publications - Jesús Miguel Torres-Flores
Laboratorio Nacional de Vacunología y Virus Tropicales, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México 11340, Mexico
5 shared publications - Roberto Ruiz-Medrano
Departamento de Biotecnología y Bioingeniería, Centro de Investigación y de Estudios Avanzados, Av. Instituto Politécnico Nacional 2508, Col. San Pedro Zacatenco, Mexico City 07360, Mexico
5 shared publications - Leticia Bucio-Ortiz
Experimental and Translational Medicine, Health Sciences Department, Universidad Autónoma Metropolitana-Iztapalapa, Mexico City 09340, Mexico
4 shared publications
Latest Publications
- Open Access
Detection of Dengue Virus Serotype 3 Using a Colorimetric Reverse Transcription Loop-Mediated Isothermal Amplification Assay: Evaluation with Clinical Samples from Southeastern Mexico
Dengue virus (DENV), an important mosquito-borne orthoflavivirus, represents a growing global threat due to its geographic expansion and recent outbreaks worldwide. In resource-limited endemic settings, the development of affordable diagnostic assays is needed. In this study, we developed and validated a colorimetric reverse transcription loop-mediated isothermal amplification assay (RT-LAMP) for the detection of DENV type 3 (DENV-3) using 95 previously diagnosed clinical samples from Southeastern Mexico. Primers targeting the 3′ untranslated region (3′ UTR) of DENV-3 were designed, and assay conditions were standardized. The colorimetric RT-LAMP DENV-3 system achieved a preliminary limit of detection of 1 × 103 copies per reaction, with 90.7% sensitivity and 100% specificity. The colorimetric format enabled visual readout without specialized equipment, supporting its potential applicability in point-of-care and resource-limited settings. The developed colorimetric RT-LAMP detection for DENV-3 is intended as a rapid screening/triage tool that can trigger confirmatory testing or public-health actions.
Open AccessDetection of Dengue Virus Serotype 3 Using a Colorimetric Reverse Transcription Loop-Mediated Isothermal Amplification Assay: Evaluation with Clinical Samples from Southeastern Mexico
Dengue virus (DENV), an important mosquito-borne orthoflavivirus, represents a growing global threat due to its geographic expansion and recent outbreaks worldwide. In resource-limited endemic settings, the development of affordable diagnostic assays is needed. In this study, we developed and validated a colorimetric reverse transcription loop-mediated isothermal amplification assay (RT-LAMP) for the detection of DENV type 3 (DENV-3) using 95 previously diagnosed clinical samples from Southeastern Mexico. Primers targeting the 3′ untranslated region (3′ UTR) of DENV-3 were designed, and assay conditions were standardized. The colorimetric RT-LAMP DENV-3 system achieved a preliminary limit of detection of 1 × 103 copies per reaction, with 90.7% sensitivity and 100% specificity. The colorimetric format enabled visual readout without specialized equipment, supporting its potential applicability in point-of-care and resource-limited settings. The developed colorimetric RT-LAMP detection for DENV-3 is intended as a rapid screening/triage tool that can trigger confirmatory testing or public-health actions.
- Open Access
Advances in the Elimination of Viral Hepatitis in Mexico: A Local Perspective on the Global Initiative
Viral hepatitis (A–E) presents a major global health challenge. In 2015, the World Health Organization (WHO) launched an initiative to eliminate viral hepatitis, with the aim of reducing new infections by 90% and deaths by 65% by 2030. Mexico is one of 38 focus countries identified by the WHO, collectively accounting for 80% of global infections and deaths. While hepatitis B and C are commonly diagnosed in Mexico, routine diagnosis for hepatitis D and E is lacking, with no specific epidemiological data available. In 2020, Mexico implemented the National Hepatitis C Elimination Program, focusing on preventing new infections, reducing complications like cirrhosis and hepatocellular carcinoma, ensuring access to treatment, and improving patient care. However, this program has not been extended to hepatitis B and E. Addressing the challenges of viral hepatitis control in Mexico requires increased resource allocation, expanded diagnosis, vaccination for hepatitis A and B, and treatment coverage for hepatitis B and C, along with multisectoral engagement. This work provides an overview of Mexico’s response to the global initiative, highlighting its progress, challenges, and areas of opportunity.
Open AccessAdvances in the Elimination of Viral Hepatitis in Mexico: A Local Perspective on the Global Initiative
Viral hepatitis (A–E) presents a major global health challenge. In 2015, the World Health Organization (WHO) launched an initiative to eliminate viral hepatitis, with the aim of reducing new infections by 90% and deaths by 65% by 2030. Mexico is one of 38 focus countries identified by the WHO, collectively accounting for 80% of global infections and deaths. While hepatitis B and C are commonly diagnosed in Mexico, routine diagnosis for hepatitis D and E is lacking, with no specific epidemiological data available. In 2020, Mexico implemented the National Hepatitis C Elimination Program, focusing on preventing new infections, reducing complications like cirrhosis and hepatocellular carcinoma, ensuring access to treatment, and improving patient care. However, this program has not been extended to hepatitis B and E. Addressing the challenges of viral hepatitis control in Mexico requires increased resource allocation, expanded diagnosis, vaccination for hepatitis A and B, and treatment coverage for hepatitis B and C, along with multisectoral engagement. This work provides an overview of Mexico’s response to the global initiative, highlighting its progress, challenges, and areas of opportunity.
- Open Access
Occult Hepatitis B Virus Infection in Hepatic Diseases and Its Significance for the WHO’s Elimination Plan of Viral Hepatitis
Liver damage can progress through different stages, resulting in cirrhosis or hepatocellular carcinoma (HCC), conditions that are often associated with viral infections. Globally, 42% and 21% of cirrhosis cases correlate with HBV and HCV, respectively. In the Americas, the prevalence ranges from 1% to 44%. The WHO has the goal to eliminate viral hepatitis, but it is important to consider occult HBV infection (OBI), a clinical condition characterized by the presence of HBV genomes despite negative surface antigen tests. This review aims to provide an overview of recent data on OBI, focusing on its role in the development of hepatic diseases and its significance in the WHO Viral Hepatitis Elimination Plan. Specific HBV gene mutations have been linked to HCC and other liver diseases. Factors related to the interactions between OBI and mutated viral proteins, which induce endoplasmic reticulum stress and oxidative DNA damage, and the potential role of HBV integration sites (such as the TERT promoter) have been identified in HCC/OBI patients. Health initiatives for OBI research in Latin American countries are crucial to achieving the WHO’s goal of eradicating viral hepatitis by 2030, given the difficulty in diagnosing OBI and its unclear association with hepatic diseases.
Open AccessOccult Hepatitis B Virus Infection in Hepatic Diseases and Its Significance for the WHO’s Elimination Plan of Viral Hepatitis
Liver damage can progress through different stages, resulting in cirrhosis or hepatocellular carcinoma (HCC), conditions that are often associated with viral infections. Globally, 42% and 21% of cirrhosis cases correlate with HBV and HCV, respectively. In the Americas, the prevalence ranges from 1% to 44%. The WHO has the goal to eliminate viral hepatitis, but it is important to consider occult HBV infection (OBI), a clinical condition characterized by the presence of HBV genomes despite negative surface antigen tests. This review aims to provide an overview of recent data on OBI, focusing on its role in the development of hepatic diseases and its significance in the WHO Viral Hepatitis Elimination Plan. Specific HBV gene mutations have been linked to HCC and other liver diseases. Factors related to the interactions between OBI and mutated viral proteins, which induce endoplasmic reticulum stress and oxidative DNA damage, and the potential role of HBV integration sites (such as the TERT promoter) have been identified in HCC/OBI patients. Health initiatives for OBI research in Latin American countries are crucial to achieving the WHO’s goal of eradicating viral hepatitis by 2030, given the difficulty in diagnosing OBI and its unclear association with hepatic diseases.
- Open Access
- 27 November 2023
- Published by Universidad Autonoma Metropolitana
Avances de las mujeres en las ciencias, las humanidades y todas las disciplinas. Libro científico II 2023
Este libro contiene un conjunto de artículos científicos realizados en el contexto de la contingencia por COVID 19, desde los enfoques de las ciencias de la salud y las ciencias sociales. Su fin último es dar a conocer los avances científicos desde la perspectiva de género. De esta manera, la compilación incluye semblanzas de tres figuras relevantes de la academia mexicana: Ana Rosa López-Ferrari Aralia López González y Silvana Levi Levi con el propósito de sistematizar los aportes de cada una en los campos de la literatura, la botánica y la geografía respectivamente analizando de forma integral otros aspectos relevantes de lo que Bourdieu llamaría sus condiciones sociales de posibilidad. Por otro lado los artículos que conforman el libro se enfocan en: El estudio de posibles causas de la obesidad; exploraron los efectos psicológicos del confinamiento provocado por la pandemia por COVID 19 sobre los hábitos alimenticios y del sueño respectivamente; la experiencia exitosa de transformación cultivo de hortalizas de forma orgánica y sustentable durante un proceso de sobrevivencia y adaptación a las duras condiciones económicas y sociales producidas por la pandemia por COVID-19; La investigación con resultados alentadores, las características de sustancias que tentativamente puedan reemplazar aquellas con las que se trata el glioblastoma, de una manera más eficiente y con menos efectos colaterales; El incremento de los conflictos domésticos, la violencia por razones de género y feminicidios durante la pandemia; La valoración de los marcos de competencias digitales en España para diferentes áreas académicas en las que se implementó la educación a distancia con motivo de la pandemia por COVID-19.
- 27 November 2023
- Published by Universidad Autonoma Metropolitana
Open AccessAvances de las mujeres en las ciencias, las humanidades y todas las disciplinas. Libro científico II 2023
Este libro contiene un conjunto de artículos científicos realizados en el contexto de la contingencia por COVID 19, desde los enfoques de las ciencias de la salud y las ciencias sociales. Su fin último es dar a conocer los avances científicos desde la perspectiva de género. De esta manera, la compilación incluye semblanzas de tres figuras relevantes de la academia mexicana: Ana Rosa López-Ferrari Aralia López González y Silvana Levi Levi con el propósito de sistematizar los aportes de cada una en los campos de la literatura, la botánica y la geografía respectivamente analizando de forma integral otros aspectos relevantes de lo que Bourdieu llamaría sus condiciones sociales de posibilidad. Por otro lado los artículos que conforman el libro se enfocan en: El estudio de posibles causas de la obesidad; exploraron los efectos psicológicos del confinamiento provocado por la pandemia por COVID 19 sobre los hábitos alimenticios y del sueño respectivamente; la experiencia exitosa de transformación cultivo de hortalizas de forma orgánica y sustentable durante un proceso de sobrevivencia y adaptación a las duras condiciones económicas y sociales producidas por la pandemia por COVID-19; La investigación con resultados alentadores, las características de sustancias que tentativamente puedan reemplazar aquellas con las que se trata el glioblastoma, de una manera más eficiente y con menos efectos colaterales; El incremento de los conflictos domésticos, la violencia por razones de género y feminicidios durante la pandemia; La valoración de los marcos de competencias digitales en España para diferentes áreas académicas en las que se implementó la educación a distancia con motivo de la pandemia por COVID-19.
- 1 November 2023
- Published by Universidad Autonoma Metropolitana
- p. 129-143
Katalin Karikó y su papel crucial en el desarrollo de las vacunas de ARN mensajero contra el COVID-19
In December 2019, a new coronavirus was reported in Wuhan, China. SARSCoV-2 is a very contagious virus that causes the Coronavirus Disease-19 (COVID-19) and the WHO declared COVID-19 a pandemic on March 11, 2020. Despite the efforts to contain the virus dissemination, the pandemic has caused the death of more than 5 million persons in the world. Therefore, the urgent need to develop vaccines against COVID-19 has been evidenced. The goal of this article is to know the Katalin Karikó contributions to develop RNA vaccines, and the impact in the control of the COVID-19 pandemic. Seven vaccines have received the emergency use authorization (EUA). The first vaccines to be approved were developed under novel platforms that utilize either mRNA or adenoviral vectors. A vaccine trains our immune system to recognize and combat pathogen and preventing infection. The mRNA vaccines are based in the introduction of the mRNA that encodes the spike protein (S) to trigger an immune response against SARS-CoV-2, reducing the symptomatic severe disease and death. Besides the vaccines can be synthetized in the laboratory, they are safe and induce an immune response. The technological advances in the knowledge of RNA were the key to obtain a COVID-19 vaccine in record time and this was possible thanks to the contributions of the great Hungarian researcher Katalin Karikó, her contributions were particularly important in the development of these vaccines. She was interested since the 90´s in the RNA synthesis. Karikó and Drew Weissman demonstrated that the modification of one nucleotide, the pseudouridine in the mRNA eliminated the exacerbated inflammation when inoculated in a mouse. They also found the form to preserve the RNA integrity and deliver it to mice using a lipid nanoparticle. In this moment, when science is fighting the coronavirus pandemic, the advances in this novel biotechnological platform has been determinant in the rapid development of vaccines that are the hope to the humanity to overcome the pandemic.
- 1 November 2023
- Published by Universidad Autonoma Metropolitana
- p. 129-143
Katalin Karikó y su papel crucial en el desarrollo de las vacunas de ARN mensajero contra el COVID-19
In December 2019, a new coronavirus was reported in Wuhan, China. SARSCoV-2 is a very contagious virus that causes the Coronavirus Disease-19 (COVID-19) and the WHO declared COVID-19 a pandemic on March 11, 2020. Despite the efforts to contain the virus dissemination, the pandemic has caused the death of more than 5 million persons in the world. Therefore, the urgent need to develop vaccines against COVID-19 has been evidenced. The goal of this article is to know the Katalin Karikó contributions to develop RNA vaccines, and the impact in the control of the COVID-19 pandemic. Seven vaccines have received the emergency use authorization (EUA). The first vaccines to be approved were developed under novel platforms that utilize either mRNA or adenoviral vectors. A vaccine trains our immune system to recognize and combat pathogen and preventing infection. The mRNA vaccines are based in the introduction of the mRNA that encodes the spike protein (S) to trigger an immune response against SARS-CoV-2, reducing the symptomatic severe disease and death. Besides the vaccines can be synthetized in the laboratory, they are safe and induce an immune response. The technological advances in the knowledge of RNA were the key to obtain a COVID-19 vaccine in record time and this was possible thanks to the contributions of the great Hungarian researcher Katalin Karikó, her contributions were particularly important in the development of these vaccines. She was interested since the 90´s in the RNA synthesis. Karikó and Drew Weissman demonstrated that the modification of one nucleotide, the pseudouridine in the mRNA eliminated the exacerbated inflammation when inoculated in a mouse. They also found the form to preserve the RNA integrity and deliver it to mice using a lipid nanoparticle. In this moment, when science is fighting the coronavirus pandemic, the advances in this novel biotechnological platform has been determinant in the rapid development of vaccines that are the hope to the humanity to overcome the pandemic.
- 4 October 2023
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 109 (4) , 933-936
Dried Serum Samples for Antibody Detection in Arthropod-Borne Virus Infections Are an Effective Alternative to Serum Samples
: The disease burden of arthropod-borne infections is particularly high in low- and middle-income countries, where the availability of resources for surveillance and testing is limited. The lack of local infrastructure demands that biological samples be sent to central laboratories by refrigerated transport, which increases costs and the risk of sample degradation. Dried blood spot samples are an alternative for ensuring sample integrity during transportation and storage. They can be used for the detection of nucleic acids and proteins, such as antigens or antibodies. Here, we compared anti-chikungunya IgM, anti-dengue IgM, anti-dengue IgG, and anti-Zika IgG detection between paired serum and dried serum samples (DSSs); the agreement between results was found to be 90.6%, 94.1%, 85.9%, and 95.5%, respectively, indicating a strong correlation. Our results suggest that DSSs provide a reliable alternative for detection of specific antibodies in arthropod-borne infections.
- 4 October 2023
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 109 (4) , 933-936
Dried Serum Samples for Antibody Detection in Arthropod-Borne Virus Infections Are an Effective Alternative to Serum Samples
: The disease burden of arthropod-borne infections is particularly high in low- and middle-income countries, where the availability of resources for surveillance and testing is limited. The lack of local infrastructure demands that biological samples be sent to central laboratories by refrigerated transport, which increases costs and the risk of sample degradation. Dried blood spot samples are an alternative for ensuring sample integrity during transportation and storage. They can be used for the detection of nucleic acids and proteins, such as antigens or antibodies. Here, we compared anti-chikungunya IgM, anti-dengue IgM, anti-dengue IgG, and anti-Zika IgG detection between paired serum and dried serum samples (DSSs); the agreement between results was found to be 90.6%, 94.1%, 85.9%, and 95.5%, respectively, indicating a strong correlation. Our results suggest that DSSs provide a reliable alternative for detection of specific antibodies in arthropod-borne infections.
- Open Access
Donated Blood Screening for HIV, HCV and HBV by ID-NAT and the Residual Risk of Iatrogenic Transmission in a Tertiary Care Hospital Blood Bank in Puebla, Mexico
Hepatitis C virus (HCV), human immunodeficiency virus (HIV) and hepatitis B virus (HBV) can be transmitted by blood transfusion. Most transmission occurs during the acute viremic phase (AVP), before antibody development. To reduce transmission risk, individual donor nucleic acid testing (ID-NAT) is used. In Puebla, Mexico, serological tests and ID-NAT have been applied to screen blood donors and detect individuals in AVP. In the present study, 106,125 blood donors’ data in two periods (2012–2015 and 2017–2019) were analyzed. The residual risk (RR) values were calculated considering ID-NAT results. The RR for HIV was 14 in 1 million donations or 1 in 71,428, the RR for HVC was 6.8 in 1 million donations or 1 in 147,058 and, for HBV, it was 156 in 1 million donations, or 1 in 6410. Previously, it was predicted that the transmission RR of these viruses would be reduced in Mexico through better screening with NAT. The use of ID-NAT has, indeed, increased the safety of blood reserves for HIV and HCV. However, more research is needed to determine why the residual risk of HBV did not decrease as much over the study period. ID-NAT is an important complementary tool for blood donor screening that should be implemented.
Open AccessDonated Blood Screening for HIV, HCV and HBV by ID-NAT and the Residual Risk of Iatrogenic Transmission in a Tertiary Care Hospital Blood Bank in Puebla, Mexico
Hepatitis C virus (HCV), human immunodeficiency virus (HIV) and hepatitis B virus (HBV) can be transmitted by blood transfusion. Most transmission occurs during the acute viremic phase (AVP), before antibody development. To reduce transmission risk, individual donor nucleic acid testing (ID-NAT) is used. In Puebla, Mexico, serological tests and ID-NAT have been applied to screen blood donors and detect individuals in AVP. In the present study, 106,125 blood donors’ data in two periods (2012–2015 and 2017–2019) were analyzed. The residual risk (RR) values were calculated considering ID-NAT results. The RR for HIV was 14 in 1 million donations or 1 in 71,428, the RR for HVC was 6.8 in 1 million donations or 1 in 147,058 and, for HBV, it was 156 in 1 million donations, or 1 in 6410. Previously, it was predicted that the transmission RR of these viruses would be reduced in Mexico through better screening with NAT. The use of ID-NAT has, indeed, increased the safety of blood reserves for HIV and HCV. However, more research is needed to determine why the residual risk of HBV did not decrease as much over the study period. ID-NAT is an important complementary tool for blood donor screening that should be implemented.
- Open Access
- 26 January 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (1) , e0279681
Starting from scratch: Step-by-step development of diagnostic tests for SARS-CoV-2 detection by RT-LAMP
The pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide. Public health strategies to reduce viral transmission are based on widespread diagnostic testing to detect and isolate contagious patients. Several reverse transcription (RT)-PCR tests, along with other SARS-CoV-2 diagnostic assays, are available to attempt to cover the global demand. Loop-mediated isothermal amplification (LAMP) based methods have been established as rapid, accurate, point of care diagnostic tests for viral infections; hence, they represent an excellent alternative for SARS-CoV-2 detection. The aim of this study was to develop and describe molecular detection systems for SARS-CoV-2 based on RT-LAMP. Recombinant DNA polymerase fromBacillus stearothermophilusand thermostable engineered reverse transcriptase from Moloney Murine Leukemia Virus were expressed using a prokaryotic system and purified by fast protein liquid chromatography. These enzymes were used to set up fluorometric real time and colorimetric end-point RT-LAMP assays. Several reaction conditions were optimized such as reaction temperature, Tris-HCl concentration, and pH of the diagnostic tests. The key enzymes for RT-LAMP were purified and their enzymatic activity was determined. Standardized reaction conditions for both RT-LAMP assays were 65°C and a Tris-HCl-free buffer at pH 8.8. Colorimetric end-point RT-LAMP assay was successfully used for viral detection from clinical saliva samples with 100% sensitivity and 100% specificity compared to the results obtained by RT-qPCR based diagnostic protocols with Ct values until 30. The developed RT-LAMP diagnostic tests based on purified recombinant enzymes allowed a sensitive and specific detection of the nucleocapsid gene of SARS-CoV-2.
- 26 January 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (1) , e0279681
Open AccessStarting from scratch: Step-by-step development of diagnostic tests for SARS-CoV-2 detection by RT-LAMP
The pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide. Public health strategies to reduce viral transmission are based on widespread diagnostic testing to detect and isolate contagious patients. Several reverse transcription (RT)-PCR tests, along with other SARS-CoV-2 diagnostic assays, are available to attempt to cover the global demand. Loop-mediated isothermal amplification (LAMP) based methods have been established as rapid, accurate, point of care diagnostic tests for viral infections; hence, they represent an excellent alternative for SARS-CoV-2 detection. The aim of this study was to develop and describe molecular detection systems for SARS-CoV-2 based on RT-LAMP. Recombinant DNA polymerase fromBacillus stearothermophilusand thermostable engineered reverse transcriptase from Moloney Murine Leukemia Virus were expressed using a prokaryotic system and purified by fast protein liquid chromatography. These enzymes were used to set up fluorometric real time and colorimetric end-point RT-LAMP assays. Several reaction conditions were optimized such as reaction temperature, Tris-HCl concentration, and pH of the diagnostic tests. The key enzymes for RT-LAMP were purified and their enzymatic activity was determined. Standardized reaction conditions for both RT-LAMP assays were 65°C and a Tris-HCl-free buffer at pH 8.8. Colorimetric end-point RT-LAMP assay was successfully used for viral detection from clinical saliva samples with 100% sensitivity and 100% specificity compared to the results obtained by RT-qPCR based diagnostic protocols with Ct values until 30. The developed RT-LAMP diagnostic tests based on purified recombinant enzymes allowed a sensitive and specific detection of the nucleocapsid gene of SARS-CoV-2.
- 4 May 2022
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 18 (7) , 505-510
Retrospective study of HIV drug resistance in Mexican children with vertically transmitted infection
- 4 May 2022
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 18 (7) , 505-510
Retrospective study of HIV drug resistance in Mexican children with vertically transmitted infection